Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-042407
Filing Date
2023-09-01
Accepted
2023-09-01 17:00:21
Documents
2
Period of Report
2023-08-28

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1397
2 EXHIBIT 24 brhc20058338_ex24.htm EX-24 8095
  Complete submission text file 0001140361-23-042407.txt   11181
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ETERNA THERAPEUTICS INC. 1035 CAMBRIDGE STREET, STE. 18A CAMBRIDGE MA 02141
Business Address
Clarke Dorothy J (Reporting) CIK: 0001992152 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 231233265